# Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

> clinical trial · VERIFIED · 2026-07-20

Status: ACTIVE_NOT_RECRUITING · Sponsor: Sanofi · Condition: Multiple Sclerosis

- Company: Sanofi
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT06141473

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.